| SC 13D/A | 2012-10-22 | ALTA BIOPHARMA PARTNERS III LP | Aegerion Pharmaceuticals, Inc. | 1,998,552 | 7.8% | EDGAR |
| SC 13G | 2012-10-10 | FMR LLC | Aegerion Pharmaceuticals, Inc. | 2,639,394 | 10.4% | EDGAR |
| SC 13G/A | 2012-02-14 | WELLINGTON MANAGEMENT CO LLP | Aegerion Pharmaceuticals, Inc. | 474,656 | 2.2% | EDGAR |
| SC 13G | 2012-02-10 | PERCEPTIVE ADVISORS LLC | Aegerion Pharmaceuticals, Inc. | 1,253,354 | 5.9% | EDGAR |
| SC 13G/A | 2012-02-07 | MVM International Life Sciences Fund No 1 L P | Aegerion Pharmaceuticals, Inc. | 318,951 | 1.5% | EDGAR |
| SC 13D/A | 2012-02-01 | ADVENT INTERNATIONAL CORP/MA | Aegerion Pharmaceuticals, Inc. | 2,632,879 | 12.4% | EDGAR |
| SC 13G | 2012-01-17 | JPMORGAN CHASE & CO | Aegerion Pharmaceuticals, Inc. | 1,386,847 | 6.5% | EDGAR |
| SC 13D/A | 2011-07-07 | Index Venture Associates III Ltd | Aegerion Pharmaceuticals, Inc. | 2,168,435 | 10.4% | EDGAR |
| SC 13G | 2011-03-21 | MVM International Life Sciences Fund No 1 L P | Aegerion Pharmaceuticals, Inc. | 949,326 | 5.4% | EDGAR |
| SC 13G | 2011-02-14 | WELLINGTON MANAGEMENT CO LLP | Aegerion Pharmaceuticals, Inc. | 1,360,100 | 7.7% | EDGAR |
| SC 13D | 2010-11-10 | ADVENT INTERNATIONAL CORP/MA | Aegerion Pharmaceuticals, Inc. | 2,786,110 | 15.8% | EDGAR |
| SC 13D | 2010-11-08 | ALTA BIOPHARMA PARTNERS III LP | Aegerion Pharmaceuticals, Inc. | 2,455,167 | 14.0% | EDGAR |
| SC 13D | 2010-11-08 | Index Venture Associates III Ltd | Aegerion Pharmaceuticals, Inc. | 3,046,158 | - | EDGAR |